Research Papers

25 of 114 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Particulate generation with different oxygen delivery devices.
Helgeson SA; Lee AS; Lim KG; Niven AS; Patel NM.
Respir Med (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity.
Blasi F; Gramegna A; Sotgiu G; Saderi L; Voza A; Aliberti S; Amati F.
Respir Med (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
COVID-19: Why does disease severity vary among individuals?
Samadizadeh S; Masoudi M; Rastegar M; Salimi V; Shahbaz MB; Tahamtan A.
Respir Med (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
The use of oxygen hoods in patients failing on conventional high-flow oxygen delivery systems, the effects on oxygenati…
Dayya D; O'Neill OJ; Feiertag TD; Tuazon-Boer R; Sullivan J; Perez L; Gurash S; Eaton M; Bodley T; Marker J; Smykowski E; Hall T.
Respir Med (Unknown)
Published: 2021
3/6 Transparent
Registered Funding Declared
Factors associated with delayed viral shedding in COVID-19 infected patients: A retrospective small-scale study.
Cao HR; Zhu XY; Zhou L; Zhang H; Gu BB; Tang W; Ding J; Huang J; Shen XH; Chen C.
Respir Med (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Incidence of pulmonary embolism in patients with non-invasive respiratory support during COVID-19 outbreak.
González-García JG; Pascual-Guardia S; Aguilar Colindres RJ; Ausín Herrero P; Alvarado Miranda M; Arita Guevara M; Badenes Bonet D; Bellido Calduch S; Caguana Vélez OA; Cumpli Gargallo C; Dominguez-Alvarez M; Gea J; Grau N; Khilzi K; Martínez-Llorens J; Sánchez Ortiz M; Sánchez-Font A; Sancho-Muñoz A; Parrilla-Gómez FJ; Marín Corral J; Pérez Terán P; Rodríguez-Sevilla JJ; Chalela R; Rodríguez-Chiaradia D.
Respir Med (Unknown)
Published: 2021
1/6 Transparent
Long-term exposure to fine particulate matter and hospitalization in COVID-19 patients.
Mendy A; Wu X; Keller JL; Fassler CS; Apewokin S; Mersha TB; Xie C; Pinney SM.
Respir Med (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Colchicine and SARS-CoV-2: Management of the hyperinflammatory state.
Vitiello A; Ferrara F.
Respir Med (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Effect of patient immunodeficiencies on the diagnostic performance of serological assays to detect Aspergillus-specific…
Hunter ES; Wilopo B; Richardson MD; Kosmidis C; Denning DW.
Respir Med (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Suggestions for lung function testing in the context of COVID-19.
Milanese M; Corsico AG; Bellofiore S; Carrozzi L; Di Marco F; Iovene B; Richeldi L; Sanna A; Santus P; Schisano M; Scichilone N; Vancheri C; Cerveri I; SIP (Italian Respiratory Society).
Respir Med (Unknown)
Published: 2020
1/6 Transparent
Pulmonary function and health-related quality of life after COVID-19 pneumonia.
van der Sar-van der Brugge S; Talman S; Boonman-de Winter L; de Mol M; Hoefman E; van Etten RW; De Backer IC.
Respir Med (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Predictive value of chest CT scoring in COVID-19 patients in Wuhan, China: A retrospective cohort study.
Li S; Liu S; Wang B; Li Q; Zhang H; Zeng L; Ge H; Ma Q; Shen N.
Respir Med (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection.
Smet J; Stylemans D; Hanon S; Ilsen B; Verbanck S; Vanderhelst E.
Respir Med (Unknown)
Published: 2020
1/6 Transparent
Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in pati…
Liao SY; Petrache I; Fingerlin TE; Maier LA.
Respir Med (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity.
Caminati M; Vultaggio A; Matucci A; Senna G; Almerigogna F; Bagnasco D; Chieco-Bianchi F; Cosini F; Girelli D; Guarnieri G; Menzella F; Micheletto C; Olivieri O; Passalacqua G; Pini L; Rossi O; Vianello A; Vivarelli E; Crisafulli E.
Respir Med (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians.
Batah SS; Fabro AT.
Respir Med (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Asthma in COVID-19 patients: An extra chain fitting around the neck?
Hussein MH; Toraih EA; Attia AS; Burley N; Zhang AD; Roos J; Houghton A; Aniemeka N; Omar M; Aboueisha M; Shama MA; Duchesne J; Kandil E.
Respir Med (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
In-line treatments and clinical initiatives to fight against COVID-19 outbreak.
Agrawal M; Saraf S; Saraf S; Murty US; Kurundkar SB; Roy D; Joshi P; Sable D; Choudhary YK; Kesharwani P; Alexander A.
Respir Med (Unknown)
Published: 2020
1/6 Transparent
Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating C…
Gluck WL; Callahan SP; Brevetta RA; Stenbit AE; Smith WM; Martin JC; Blenda AV; Arce S; Edenfield WJ.
Respir Med (Unknown)
Published: 2020
3/6 Transparent
Registered Funding Declared
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressi…
Torre A; Aliberti S; Castellotti PF; Cirillo DM; Grisolia A; Mangioni D; Marchetti G; Rossotti R; Santus P; Besozzi G; Villa S; Codecasa LR; Milan TB-COVID-19 study group.
Respir Med (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
High-density lipoprotein cholesterol as a factor affecting virus clearance in covid-19 patients.
Ding X; Zhang J; Liu L; Yuan X; Zang X; Lu F; He P; Wang Q; Zhang X; Xu Y; Li X; Liu Y; Li Q; Tan X; Zheng Y; Lin X; Liu Y.
Respir Med (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Combining biomarkers of clot resolution and alveolar basement membrane destruction predicts mortality in the ECLIPSE CO…
Sand JMB; Rønnow SR; Langholm LL; Karsdal MA; Manon-Jensen T; Tal-Singer R; Miller BE; Vestbo J; Leeming DJ.
Respir Med (Unknown)
Published: 2020
3/6 Transparent
Registered Funding Declared
Pulmonary artery thrombi are co-located with opacifications in SARS-CoV2 induced ARDS.
Mueller-Peltzer K; Krauss T; Benndorf M; Lang CN; Bamberg F; Bode C; Duerschmied D; Staudacher DL; Zotzmann V.
Respir Med (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Ko…
Chan KPF; Ma TF; Kwok WC; Leung JKC; Chiang KY; Ho JCM; Lam DCL; Tam TCC; Ip MSM; Ho PL.
Respir Med (Unknown)
Published: 2020
1/6 Transparent
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVI…
Mondejar-Lopez P; Quintana-Gallego E; Giron-Moreno RM; Cortell-Aznar I; Ruiz de Valbuena-Maiz M; Diab-Caceres L; Prados-Sanchez C; Alvarez-Fernandez A; Garcia-Marcos PW; Peñalver-Mellado C; Pastor-Vivero MD; Olveira C; Lopez-Neyra A; Castillo-Corullon S; Palma-Milla S; Perez-Ruiz E; Sole-Jover A; Barrio MI; Sanchez-Solis M; Asensio de la Cruz Ó; CF-COVID19-Spain Registry Group.
Respir Med (Unknown)
Published: 2020
1/6 Transparent